ArticleMolecular biology reports2026
Exploring the pathogenesis of a compound heterozygous variant in ATP7B associated with Wilson disease in an Iranian family.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWilson disease (WD) is a hereditary autosomal recessive disorder of copper metabolism, which results from mutations in the ATP7B gene. It is a monogenic disorder characterized by significant clinical heterogeneity in patients with renal, ocular, hepatic, and neurological involvement, complicating its clinical diagnosis. This study involves examination of an Iranian family with a child diagnosed with WD.
methodsAfter various clinical tests, Whole Exome Sequencing (WES) and Sanger sequencing were carried out on the proband to identify the cause of the disease and verify the results. Segregation analysis was also performed. The next step was the study of protein conservation and its alterations after mutation.
resultsThe WES analysis revealed that the c.1883_1884del [p. His628ArgfsTer126] and c.2145 C > T variations in the ATP7B gene, in compound heterozygous form, were linked to WD in the proband. The analysis also determined that the proband inherited c.1883_1884del [p. His628ArgfsTer126] from his mother's side and c.2145 C > T from his father. A decrease in the amount of translated protein compared to the wild-type leads to the appearance of clinical symptoms in the affected individuals.
conclusionThis study added criteria PP1, PP4 and PS4 to c.1883_1884del [p. His628ArgfsTer126] according to the ACMG guidelines and also supports a potential reclassification of c.2145 C > T variant from variant of uncertain significance (VUS) to likely pathogenic by adding PP4 and PM3. These findings will significantly help specialists in their decision-making about these variants.
Indexed as
Identifiers
42126658What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.